AXL Inhibitors: Status of Clinical Development
Sheena Bhalla, David E. Gerber
Topics & Concepts
MedicineReceptor tyrosine kinaseClinical trialDrug developmentMetastasisCancerMonoclonal antibodyCabozantinibTyrosine kinaseDrugCancer researchOncologyInternal medicinePharmacologyAntibodyImmunologyReceptorPhagocytosis and Immune RegulationPancreatic and Hepatic Oncology ResearchNeuroblastoma Research and Treatments